Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1994 1
1995 1
1996 3
1997 1
1998 1
2002 1
2003 3
2004 1
2005 9
2006 10
2007 8
2008 15
2009 15
2010 9
2011 6
2012 8
2013 10
2014 7
2015 4
2016 8
2017 6
2018 7
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 18524974

132 results
Results by year
Filters applied: . Clear all
Page 1
No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. Langner S, et al. AJNR Am J Neuroradiol. 2008 Sep;29(8):1525-9. doi: 10.3174/ajnr.A1164. Epub 2008 Jun 4. AJNR Am J Neuroradiol. 2008. PMID: 18524974 Free article. Clinical Trial.
The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
Thomsen HS, Morcos SK, Erley CM, Grazioli L, Bonomo L, Ni Z, Romano L; Investigators in the Abdominal Computed Tomography: IOMERON 400 Versus VISIPAQUE 320 Enhancement (ACTIVE) Study. Thomsen HS, et al. Invest Radiol. 2008 Mar;43(3):170-8. doi: 10.1097/RLI.0b013e31815f3172. Invest Radiol. 2008. PMID: 18301313 Clinical Trial.
Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, Costello P, Schoepf UJ. Nguyen SA, et al. Radiology. 2008 Jul;248(1):97-105. doi: 10.1148/radiol.2481071484. Epub 2008 May 15. Radiology. 2008. PMID: 18483232 Clinical Trial.
Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol.
Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, Heiken JP, Lepanto L, Ni ZH, Ni ZH, Nelson R. Barrett BJ, et al. Invest Radiol. 2006 Nov;41(11):815-21. doi: 10.1097/01.rli.0000242807.01818.24. Invest Radiol. 2006. PMID: 17035872 Clinical Trial.
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. Mehran R, et al. JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007. JACC Cardiovasc Interv. 2009. PMID: 19463464 Free article. Clinical Trial.
Comparison of contrast-induced nephrotoxicity of iodixanol and iopromide in patients with renal insufficiency undergoing coronary angiography.
Shin DH, Choi DJ, Youn TJ, Yoon CH, Suh JW, Kim KI, Cho YS, Cho GY, Chae IH, Kim CH. Shin DH, et al. Am J Cardiol. 2011 Jul 15;108(2):189-94. doi: 10.1016/j.amjcard.2011.03.019. Epub 2011 May 3. Am J Cardiol. 2011. PMID: 21545991 Clinical Trial.
Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.
Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH. Davenport MS, et al. Radiology. 2013 Apr;267(1):94-105. doi: 10.1148/radiol.12121394. Epub 2013 Jan 29. Radiology. 2013. PMID: 23360737 Free PMC article.
Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B, Henning K, Mulligan J, Klippenstein D, Lawrence D, Gurtoo L, Gottlieb RH. Cheruvu B, et al. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):493-8. doi: 10.1097/rct.0b013e31802e29d9. J Comput Assist Tomogr. 2007. PMID: 17882021
Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
Sandstede JJ, Roth A, Machann W, Kaupert C, Hahn D. Sandstede JJ, et al. Eur J Radiol. 2007 Jul;63(1):120-3. doi: 10.1016/j.ejrad.2007.01.021. Epub 2007 Feb 21. Eur J Radiol. 2007. PMID: 17317065
[No detectable nephrotoxic side effect using a dimer, non-ionic contrast media in cerebral perfusion computed tomography in case of suspected brain ischemia].
Petrik M, Weigel C, Kirsch M, Hosten N. Petrik M, et al. Rofo. 2005 Sep;177(9):1242-9. doi: 10.1055/s-2005-858318. Rofo. 2005. PMID: 16123870 German.
132 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback